The report said on Wednesday GSK’s former head of vaccine development ... Pfizer delayed announcing its COVID shot’s success in 2020 until after that year’s election AFP via Getty Images ...

British drugmaker GSK told Manhattan ... shot's success in 2020 until after that year's election, the Wall Street Journal reported, citing people familiar with the matter. The report said on ...

The complaint filed alleges that, between February 5, 2020, and August 14 ... they failed to disclose that GSK possessed unpublished data – the Tanner Report – that did exactly that; (3 ...

Federal prosecutors in Manhattan are probing a claim by GSK ... in 2020 until after that year’s election, the Wall Street Journal reported, citing people familiar with the matter. The report ...

According to DelveInsight's analysis, the market for GIST is anticipated to increase during the forecast period (2025–2034), owing to the launch of e ...

Tucked away on an industrial estate in Essex is a building that could one day house some of the world's deadliest pathogens.

THE LAWSUIT: A class action securities lawsuit was filed against GSK plc that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 5, 2020 ...

March 27 (Reuters) - Federal prosecutors in Manhattan are probing a claim by GSK (GSK.L), opens new tab that Pfizer (PFE.N), opens new tab delayed announcing its COVID shot's success in 2020 until ...

Pfizer Inc. PFE shares are trading lower on Wednesday after a Wall Street Journal report ... GSK, alleges Pfizer may have delayed announcing the success of its vaccine trials in 2020 until after ...

The narrowed label means that, for GSK, Zejula's 2020 approval as a first-line maintenance ... according to a Reuters report. GSK acquired Zejula as part of its $5.1 billion takeover of Tesaro ...

The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.